PsyAccess
Spravato®Registry-verifiedDesignated-centers model

Reinier van Arkel

's-Hertogenbosch, Netherlands

Treatment & access

About this provider

Reinier van Arkel's esketamine team treats adults (18+) with moderate to severe depression that has not responded sufficiently to other treatments such as medication and talking therapies. The esketamine nasal spray is administered at the Jeroen Bosch Hospital in 's-Hertogenbosch, at Reinier van Arkel's outpatient clinic for older adults and day treatment. Patients initially attend twice a week, with each visit lasting about 2.5 hours; after four weeks progress is reviewed and the number of appointments is then gradually reduced. The complete treatment takes about six months. Referral goes through the patient's own practitioner or general practitioner.

Services & programs

  • Esketamine nasal spray treatment for adults (18+) with moderate to severe depression not responding to other treatments, administered under supervision at Jeroen Bosch Hospital

Common questions

Do I need a referral?

Yes. Your own practitioner can refer you to the esketamine treatment team, which first assesses whether the treatment is suitable for you. If you think you qualify, you can discuss this with your general practitioner, or with your current practitioner if you are already in treatment for depression.

What does a treatment visit look like?

At the start you come twice a week and each visit takes about 2.5 hours. The spray is administered at Reinier van Arkel's outpatient clinic for older adults and day treatment inside the Jeroen Bosch Hospital. After four weeks the team discusses how it is going, after which appointments are gradually reduced.

How long does the treatment take?

The complete treatment takes about half a year.

Who is the treatment for?

Adults from 18 years with a moderate to severe depression for whom other treatments, such as medication and talking therapies, do not help well.

Looking at alternatives? Esketamine nasal spray treatment is offered by specialised centres across the Netherlands affiliated with the national Esketamine Nasal Spray Consortium (ENC-NL); for treatment-resistant depression it has been reimbursed from the basic health insurance package since September 2021.

Verification

This record was taken directly from an official registry or program list and is re-checked on a rolling cadence.

Spotted an error? See our methodology for how records are checked and how to report a correction.